|1.||Denjoy, Isabelle: 3 articles (04/2014 - 05/2004)|
|2.||Wolpert, Christian: 3 articles (04/2007 - 04/2004)|
|3.||Haissaguerre, Michel: 3 articles (04/2007 - 04/2004)|
|4.||Leenhardt, Antoine: 2 articles (04/2014 - 05/2004)|
|5.||Extramiana, Fabrice: 2 articles (04/2014 - 05/2004)|
|6.||Hermida, Jean-Sylvain: 2 articles (04/2014 - 05/2004)|
|7.||Schott, Jean-Jacques: 2 articles (04/2007 - 01/2006)|
|8.||Probst, Vincent: 2 articles (04/2007 - 01/2006)|
|9.||Borggrefe, Martin: 2 articles (10/2006 - 04/2004)|
|10.||Gaita, Fiorenzo: 2 articles (10/2006 - 04/2004)|
|1.||Muscle Cramp (Cramp)
02/22/1997 - "In our study, 300 mg hydroquinine was safe to take in the short-term and significantly more effective than placebo in the prevention of frequent, ordinary muscle cramps. "
04/01/1994 - "In this study a daily dose of 300 mg hydroquinine hydrobromide was effective in preventing frequent ordinary muscle cramp in healthy female volunteers. "
04/01/1994 - "In order to compare the efficacy of a daily dose of 300 mg hydroquinine hydrobromide and placebo in preventing frequent ordinary muscle cramp, we designed a randomized, double-blind, placebo-controlled study of three consecutive 2-week periods viz. "
04/01/1994 - "Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration."
05/03/1997 - "Randomised controlled trial of hydroquinine in muscle cramps."
09/01/1985 - "Electrophysiological investigations were used to test the efficacy of dihydroquinidine chlorhydrate (600 or 1 200 mg/day) in a prospective study of 18 patients with recurrent ventricular tachycardia documented by electrocardiography. "
07/01/1997 - "The purpose of the study was to evaluate the correlations between baseline heart rate variability in ambulatory electrocardiographic recordings of patients with sustained ventricular tachycardia and the response to hydroquinidine on VT inducibility, and to look for the changes in heart rate variability during hydroquinidine treatment. "
09/01/1985 - "After hydroquinidine it was not possible to induce ventricular tachycardia in 10 patients (58.8%). "
09/01/1985 - "The effect of hydroquinidine on ventricular tachycardia induced by programmed pacing was evaluated after a 48 to 72 hours treatment, 3 to 5 hours after the last dose. "
09/01/1985 - "[Treatment of recurrent ventricular tachycardia with hydroquinidine. "
09/01/1985 - "The results of this study demonstrate the efficacy of hydroquinidine for the prevention of tachycardia induced by stimulation and underline its value in the treatment of sustained, recurrent ventricular tachycardia. "
09/01/1985 - "In one case, hydroquinidine aggravated the arrhythmia as the induced tachycardia had a shorter cycle. "
09/01/1989 - "This study investigated the time-dependent contributions of quinidine, dihydroquinidine, and the quinidine metabolites to the electrophysiologic effects of a prolonged quinidine infusion in 14 patients referred for management of symptomatic ventricular tachyarrhythmias. "
09/01/1985 - "In the other patients, hydroquinidine lengthened the tachycardia cycle by an average of 94 +/- 79 ms. The right ventricular refractory period increased cycle by 44 +/- 23 ms. Long-term hydroquinidine was prescribed for 7 patients, twice in association with amiodarone. "
01/01/1981 - "Bepridil depressed the tachycardia and ventricular fibrillation induced by perfusing aconitine in anesthetized guinea-pigs at doses of the same order of magnitude as for disopyramide and hydroquinidine. "
|4.||Ventricular Premature Complexes (Premature Ventricular Contraction)
03/01/1987 - "[Pharmacokinetics and efficacy of delayed-action hydroquinidine in patients with ventricular extrasystole]."
09/01/1983 - "Holter monitoring comparative assessment of propafenone and dihydroquinidine efficacy in the treatment of premature ventricular beats."
12/01/1988 - "The aim of this study was to compare the pharmacokinetics and antiarrhythmic activity of dihydroquinidine and quinidine in 14 patients (11 men, 3 women, aged 28 to 67 years) with heart disease and chronic, stable, high-frequency premature ventricular beats (PVB) (greater than 100/hr). "
|5.||Restless Legs Syndrome (Restless Legs)
04/27/1991 - "This study showed no significant differences between the efficacy of placebo or hydroquinine in the restless legs syndrome."
04/27/1991 - "Determination of the efficacy of hydroquinine treatment of the restless legs syndrome. "
04/27/1991 - "[No difference in efficacy of hydroquinine and placebo in restless legs syndrome]."
|8.||Sotalol (Sotalol Hydrochloride)
|2.||Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
|3.||Electric Countershock (Cardioversion)